Featured Research

from universities, journals, and other organizations

Potential therapy for incurable Charcot-Marie-Tooth disease found

Date:
August 27, 2014
Source:
Max-Planck-Gesellschaft
Summary:
A potential new treatment approach for hereditary neurological disorder, the incurable Charcot-Marie-Tooth disease, has been found by researchers. Patients with Charcot-Marie-Tooth disease type 1A harbour an extra copy of the PMP22 gene which leads to the overproduction of the peripheral myelin protein 22 (PMP22), a key component of myelin.

Electron microscopic images of cross sections of nerves in a healthy rat (left), a rat suffering from CMT1A (centre) and a rat suffering from CMT1A that has been treated with neuregulin-1 (right). The neuregulin-1 treatment leads to improved myelination in the CMT1A rat model, which comes close to that of healthy animals.
Credit: © Fledrich et al, Nat. Med. 2014

Charcot-Marie-Tooth disease type 1A is the most common inherited disease affecting the peripheral nervous system. Researchers from the Department of Neurogenetics at the Max Planck Institute of Experimental Medicine and University Medical Centre Göttingen have discovered that the maturity of Schwann cells is impaired in rats with the disease. These cells enwrap the nerve fibres with an insulating layer known as myelin, which facilitates the rapid transfer of electrical impulses. If Schwann cells cannot mature correctly, an insufficient number of nerve fibres is covered with myelin during development. According to the researchers, the growth factor neuregulin-1 has immense therapeutic potential: rats treated with neuregulin-1 have more myelinated nerve fibres. The symptoms of the disease diminish significantly as a result.

Patients with Charcot-Marie-Tooth disease type 1A harbour an extra copy of the PMP22 gene which leads to the overproduction of the peripheral myelin protein 22 (PMP22), a key component of myelin. This causes slow, progressive nerve damage, which can begin as early as childhood. Patients suffer from numbness, tingling and pains in the arms and legs, as well as weakness of leg and arm muscles. Some patients can only move around with the help of a wheelchair. The disease has been incurable to date, as little is known about the fundamental mechanisms of the disorder.

The researchers in Göttingen have now studied genetically modified rats, which, like Charcot-Marie-Tooth patients, produce too much PMP22. In these animals, the Schwann cells cannot mature properly, with the result that insufficient numbers of axons are enwrapped with myelin during development. "This is caused by an imbalance of two signalling pathways in the Schwann cells -- the PI3K/AKT and the MEK/ERK signalling pathway -- which are important for cellmaturation ," explains Robert Fledrich from the Max Planck Institute of Experimental Medicine.

In this latest study, the scientists tested the therapeutic potential of the growth factor neuregulin-1. They were able to show that the balance between the two signalling pathways could be restored by administering neuregulin-1. The growth factor is normally produced by nerve cells and acts as an important maturation signal for Schwann cells during development. In the case of acute nerve damage, it is also formed by Schwann cells and plays an important role in repairing damaged nerves. "In genetically modified rats, even a brief neuregulin-1 treatment within the first two weeks of life improves the animals' disease symptoms until they reach adulthood," says co-author Ruth Stassart.

The scientists and the neurologists from Michael Sereda's Research Group now want to conduct additional studies to drive forward the development of a treatment for Charcot-Marie-Tooth disease type 1A. Applying the findings to patients, however, is still a long way off. A therapy with Neuregulin itself is not safe for patients. Therefore, drugs that can imitate the neuregulin-1 signalling pathway will be tested. The recently established Germany-wide network for Charcot-Marie-Tooth disease (CMT-NET) should help in this regard. Patients, researchers and doctors will be able to use the network in Germany to find out about the progress being made in researching this little-known disease.


Story Source:

The above story is based on materials provided by Max-Planck-Gesellschaft. Note: Materials may be edited for content and length.


Journal Reference:

  1. Robert Fledrich, Ruth M Stassart, Axel Klink, Lennart M Rasch, Thomas Prukop, Lauren Haag, Dirk Czesnik, Theresa Kungl, Tamer A M Abdelaal, Naureen Keric, Christine Stadelmann, Wolfgang Brück, Klaus-Armin Nave, Michael W Sereda. Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A. Nature Medicine, 2014; DOI: 10.1038/NM.3664

Cite This Page:

Max-Planck-Gesellschaft. "Potential therapy for incurable Charcot-Marie-Tooth disease found." ScienceDaily. ScienceDaily, 27 August 2014. <www.sciencedaily.com/releases/2014/08/140827111936.htm>.
Max-Planck-Gesellschaft. (2014, August 27). Potential therapy for incurable Charcot-Marie-Tooth disease found. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2014/08/140827111936.htm
Max-Planck-Gesellschaft. "Potential therapy for incurable Charcot-Marie-Tooth disease found." ScienceDaily. www.sciencedaily.com/releases/2014/08/140827111936.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Microneedle Patch Promises Painless Pricks

Microneedle Patch Promises Painless Pricks

Reuters - Innovations Video Online (Oct. 18, 2014) — Researchers at The National University of Singapore have invented a new microneedle patch that could offer a faster and less painful delivery of drugs such as insulin and painkillers. Video provided by Reuters
Powered by NewsLook.com
Raw: Nurse Nina Pham Arrives in Maryland

Raw: Nurse Nina Pham Arrives in Maryland

AP (Oct. 17, 2014) — The first nurse to be diagnosed with Ebola at a Dallas hospital walked down the stairs of an executive jet into an ambulance at an airport in Frederick, Maryland, on Thursday. Pham will be treated at the National Institutes of Health. (Oct. 16) Video provided by AP
Powered by NewsLook.com
Raw: Cruise Ship Returns to US Over Ebola Fears

Raw: Cruise Ship Returns to US Over Ebola Fears

AP (Oct. 17, 2014) — A Caribbean cruise ship carrying a Dallas health care worker who is being monitored for signs of the Ebola virus is heading back to Texas, US, after being refused permission to dock in Cozumel, Mexico. (Oct. 17) Video provided by AP
Powered by NewsLook.com
Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

AFP (Oct. 17, 2014) — All four suspected Ebola cases admitted to hospitals in Spain on Thursday have tested negative for the deadly virus in a first round of tests, the government said Friday. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins